Catherine Scart‐Grès

943 total citations
15 papers, 239 citations indexed

About

Catherine Scart‐Grès is a scholar working on Cognitive Neuroscience, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Catherine Scart‐Grès has authored 15 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cognitive Neuroscience, 4 papers in Cellular and Molecular Neuroscience and 2 papers in Molecular Biology. Recurrent topics in Catherine Scart‐Grès's work include Sleep and Wakefulness Research (10 papers), Genetic Neurodegenerative Diseases (3 papers) and Ion channel regulation and function (1 paper). Catherine Scart‐Grès is often cited by papers focused on Sleep and Wakefulness Research (10 papers), Genetic Neurodegenerative Diseases (3 papers) and Ion channel regulation and function (1 paper). Catherine Scart‐Grès collaborates with scholars based in France, United States and Spain. Catherine Scart‐Grès's co-authors include Jean‐Charles Schwartz, Isabelle Lecomte, Jean‐Louis Pépin, Yves Dauvilliers, Jeanne‐Marie Lecomte, Ognian Georgiev, Patrick Lévy, Markku Partinen, Tarja Saaresranta and Rumen Tiholov and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Scientific Reports and SLEEP.

In The Last Decade

Catherine Scart‐Grès

14 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Scart‐Grès France 6 125 97 84 77 38 15 239
G. Guidon France 5 180 1.4× 70 0.7× 187 2.2× 58 0.8× 40 1.1× 6 286
Peta A. Pascoe Czechia 10 183 1.5× 43 0.4× 88 1.0× 117 1.5× 50 1.3× 14 352
Sara Onvani United States 6 170 1.4× 63 0.6× 141 1.7× 84 1.1× 118 3.1× 7 364
Prabhjyot Saini United States 10 315 2.5× 37 0.4× 177 2.1× 269 3.5× 41 1.1× 20 434
Amir Haghparast Iran 8 139 1.1× 94 1.0× 86 1.0× 62 0.8× 16 0.4× 19 211
Martin Striz United States 5 95 0.8× 45 0.5× 105 1.3× 59 0.8× 14 0.4× 6 178
Yuki Saito Japan 10 235 1.9× 17 0.2× 185 2.2× 149 1.9× 37 1.0× 23 371
Denys V. Volgin United States 12 187 1.5× 83 0.9× 228 2.7× 41 0.5× 63 1.7× 25 368
Alexandra Auffret France 8 60 0.5× 98 1.0× 18 0.2× 18 0.2× 41 1.1× 13 215
Claude Jacquemard France 10 232 1.9× 39 0.4× 312 3.7× 95 1.2× 40 1.1× 11 382

Countries citing papers authored by Catherine Scart‐Grès

Since Specialization
Citations

This map shows the geographic impact of Catherine Scart‐Grès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Scart‐Grès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Scart‐Grès more than expected).

Fields of papers citing papers by Catherine Scart‐Grès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Scart‐Grès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Scart‐Grès. The network helps show where Catherine Scart‐Grès may publish in the future.

Co-authorship network of co-authors of Catherine Scart‐Grès

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Scart‐Grès. A scholar is included among the top collaborators of Catherine Scart‐Grès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Scart‐Grès. Catherine Scart‐Grès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gámez, Josep, Matilde Calopa, Óscar Huertas, et al.. (2022). A proof‐of‐concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease. British Journal of Clinical Pharmacology. 89(5). 1656–1664. 5 indexed citations
2.
Gámez, Josep, Matilde Calopa, Esteban Muñoz, et al.. (2021). P.0426 Proof-of-concept study testing SOM3355 for the treatment of chorea symptoms in Huntington's disease. European Neuropsychopharmacology. 53. S310–S310. 1 indexed citations
3.
Dauvilliers, Yves, Johan Verbraecken, Markku Partinen, et al.. (2020). Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial. American Journal of Respiratory and Critical Care Medicine. 201(9). 1135–1145. 70 indexed citations
4.
Dauvilliers, Yves, Isabelle Arnulf, Zoltán Szakács, et al.. (2019). Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study. SLEEP. 42(11). 60 indexed citations
5.
Scart‐Grès, Catherine, et al.. (2019). 0614 Safety and Tolerability of Pitolisant in the Treatment of Adults With Narcolepsy: Integrated Data From Clinical Studies. SLEEP. 42(Supplement_1). A244–A245. 3 indexed citations
6.
7.
Dayno, Jeffrey M., et al.. (2019). 0612 Evaluation of Abuse Potential of the Narcolepsy Medication Pitolisant. SLEEP. 42(Supplement_1). A243–A244. 1 indexed citations
8.
Doghramji, Karl, Craig W. Davis, Albena Patroneva, et al.. (2019). Pitolisant in combination with other medications for the management of narcolepsy. Sleep Medicine. 64. S94–S94. 1 indexed citations
9.
Dauvilliers, Yves, et al.. (2019). Long-term evaluation of safety and efficacy of pitolisant in narcolepsy: harmony 3 study. Sleep Medicine. 64. S85–S85. 1 indexed citations
10.
Doghramji, Karl, Craig W. Davis, Albena Patroneva, et al.. (2019). 0615 Pitolisant in Combination With Other Medications for the Management of Narcolepsy. SLEEP. 42(Supplement_1). A245–A245. 3 indexed citations
11.
12.
Dauvilliers, Yves, Isabelle Arnulf, Zsolt Szakács, et al.. (2018). 0623 Long-Term Evaluation of Safety and Efficacy of Pitolisant In Narcolepsy: Harmony III Study. SLEEP. 41(suppl_1). A231–A232. 1 indexed citations
13.
Mandel, Jonas, Viviane Bertrand, Philippe Lehert, et al.. (2015). A meta-analysis of randomized double-blind clinical trials in CMT1A to assess the change from baseline in CMTNS and ONLS scales after one year of treatment. Orphanet Journal of Rare Diseases. 10(1). 74–74. 15 indexed citations
14.
Chumakov, Ilya, Serguei Nabirotchkin, Nathalie Cholet, et al.. (2015). Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy. Scientific Reports. 5(1). 7608–7608. 51 indexed citations
15.
Laqueille, Xavier, et al.. (2012). Revue des cas d’allongements du QTC et de torsades de pointe chez des patients traités par méthadone. L Encéphale. 38(1). 58–63. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Guidon Breakdown of academic impact, for papers by Peta A. Pascoe Breakdown of academic impact, for papers by Sara Onvani Breakdown of academic impact, for papers by Prabhjyot Saini Breakdown of academic impact, for papers by Amir Haghparast Breakdown of academic impact, for papers by Martin Striz Breakdown of academic impact, for papers by Yuki Saito Breakdown of academic impact, for papers by Denys V. Volgin Breakdown of academic impact, for papers by Alexandra Auffret Breakdown of academic impact, for papers by Claude Jacquemard
Rankless by CCL
2026